KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) EPS (Basic) (2016 - 2025)

Eli Lilly's EPS (Basic) history spans 17 years, with the latest figure at $7.4 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 51.02% year-over-year to $7.4; the TTM value through Dec 2025 reached $22.99, up 95.49%, while the annual FY2025 figure was $23.0, 95.58% up from the prior year.
  • EPS (Basic) reached $7.4 in Q4 2025 per LLY's latest filing, up from $6.22 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $7.4 in Q4 2025 to a low of -$0.06 in Q3 2023.
  • Average EPS (Basic) over 5 years is $2.68, with a median of $2.04 recorded in 2022.
  • Peak YoY movement for EPS (Basic): crashed 103.73% in 2023, then soared 1900.0% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $1.9 in 2021, then rose by 13.16% to $2.15 in 2022, then rose by 13.02% to $2.43 in 2023, then soared by 101.65% to $4.9 in 2024, then surged by 51.02% to $7.4 in 2025.
  • Per Business Quant, the three most recent readings for LLY's EPS (Basic) are $7.4 (Q4 2025), $6.22 (Q3 2025), and $6.3 (Q2 2025).